Published in Chest on September 01, 1998
Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. J Exp Med (2005) 2.82
The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther (2003) 1.56
Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort. Arthritis Res Ther (2010) 1.50
The pulmonary fibrosis-associated MUC5B promoter polymorphism does not influence the development of interstitial pneumonia in systemic sclerosis. Chest (2012) 1.10
Predictors of end stage lung disease in systemic sclerosis. Ann Rheum Dis (2003) 1.05
Scleroderma lung disease. Eur Respir Rev (2013) 1.04
A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis. Arthritis Rheum (2012) 1.02
The natural course of progressive systemic sclerosis patients with interstitial lung involvement. Clin Rheumatol (2006) 0.92
Systemic sclerosis--challenges for clinical practice. Nat Rev Rheumatol (2012) 0.92
Lung involvement in systemic sclerosis. Presse Med (2010) 0.90
The PPARγ Agonist Rosiglitazone Is Antifibrotic for Scleroderma Lung Fibroblasts: Mechanisms of Action and Differential Racial Effects. Pulm Med (2011) 0.81
Racial differences between blacks and whites with systemic sclerosis. Curr Opin Rheumatol (2012) 0.81
Race and association with disease manifestations and mortality in scleroderma: a 20-year experience at the Johns Hopkins Scleroderma Center and review of the literature. Medicine (Baltimore) (2013) 0.79
Severity of systemic sclerosis-associated pulmonary arterial hypertension in African Americans. Medicine (Baltimore) (2014) 0.78
Systemic sclerosis: demographic, clinical and serological features in 100 Iranian patients. Rheumatol Int (2013) 0.76
Enrichment of Scleroderma Vascular Disease-Associated Autoantigens in Endothelial Lineage Cells. Arthritis Rheumatol (2016) 0.76
Immunosuppression for interstitial lung disease in systemic sclerosis - novel insights and opportunities for translational research. J Cell Commun Signal (2012) 0.75
D1398G Variant of MET Is Associated with Impaired Signaling of Hepatocyte Growth Factor in Alveolar Epithelial Cells and Lung Fibroblasts. PLoS One (2016) 0.75
Genetics of systemic sclerosis: recent advances. Curr Opin Rheumatol (2015) 0.75
Pulmonary survival study in 91 patients with systemic sclerosis. Rheumatol Int (2010) 0.75
The genome of the social amoeba Dictyostelium discoideum. Nature (2005) 9.18
Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med (1994) 8.21
A psychomotor stimulant theory of addiction. Psychol Rev (1987) 6.42
Use of protein-C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans. Lancet (1997) 5.17
Neuroadaptation. Incubation of cocaine craving after withdrawal. Nature (2001) 5.14
Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis. Br J Cancer (2006) 4.93
Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial. JAMA (2000) 4.41
Metered-dose inhaler adherence in a clinical trial. Am Rev Respir Dis (1992) 4.19
Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol (1995) 4.11
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial. Ann Intern Med (2000) 4.07
Scalable and expressive medical terminologies. Proc AMIA Annu Fall Symp (1996) 4.03
Unpredictability of deception in compliance with physician-prescribed bronchodilator inhaler use in a clinical trial. Chest (2000) 3.75
MARCKS is an actin filament crosslinking protein regulated by protein kinase C and calcium-calmodulin. Nature (1992) 3.49
The minimal important difference of exercise tests in severe COPD. Eur Respir J (2010) 3.27
Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J Exp Med (1996) 3.16
A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS). Arthritis Rheum (2001) 3.15
Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res (2000) 3.03
The genome of the simian and human malaria parasite Plasmodium knowlesi. Nature (2008) 3.02
Joint injury in young adults and risk for subsequent knee and hip osteoarthritis. Ann Intern Med (2000) 3.01
Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma. N Engl J Med (2016) 2.89
Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy. Br J Cancer (2010) 2.83
Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med (1999) 2.81
New radiographic grading scales for osteoarthritis of the hand. Reliability for determining prevalence and progression. Arthritis Rheum (1989) 2.77
Regulation by phosphorylation of reversible association of a myristoylated protein kinase C substrate with the plasma membrane. Nature (1991) 2.60
Widespread divergence between incipient Anopheles gambiae species revealed by whole genome sequences. Science (2010) 2.58
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann Rheum Dis (2008) 2.55
Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J Biol Chem (1994) 2.51
Voluntary ethanol intake in rats following exposure to ethanol on various schedules. Psychopharmacologia (1973) 2.48
Body mass index in young men and the risk of subsequent knee and hip osteoarthritis. Am J Med (1999) 2.38
Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor alpha, and interferon-gamma levels in sera from patients with scleroderma. Arthritis Rheum (1992) 2.38
C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax (2006) 2.38
Upper airway pressure-flow relationships in obstructive sleep apnea. J Appl Physiol (1985) (1988) 2.34
Stroke: who's counting what? J Rehabil Res Dev (2001) 2.32
Caspase-2 is localized at the Golgi complex and cleaves golgin-160 during apoptosis. J Cell Biol (2000) 2.29
Effects of a worksite nonsmoking policy: evidence for increased cessation. Am J Public Health (1991) 2.27
Detection and incidence of specific species of spoilage bacteria on fish. II. Relative incidence of Pseudomonas putrefaciens and fluorescent pseudomonads on haddock fillets. Appl Microbiol (1968) 2.27
DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J Exp Med (1995) 2.25
Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis. Arthritis Rheum (1999) 2.22
Induction of upper airway occlusion in sleeping individuals with subatmospheric nasal pressure. J Appl Physiol (1985) (1988) 2.20
CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations. Oncogene (2008) 2.19
PRiSM Psychosis Study. Design limitations, questionable conclusions. Br J Psychiatry (1999) 2.17
Upper airway collapsibility in snorers and in patients with obstructive hypopnea and apnea. Am Rev Respir Dis (1991) 2.16
Group B streptococci during pregnancy: a comparison of two screening and treatment protocols. Am J Obstet Gynecol (1998) 2.08
The caspase-3 precursor has a cytosolic and mitochondrial distribution: implications for apoptotic signaling. J Cell Biol (1998) 2.07
Associations of IL6 polymorphisms with lung function decline and COPD. Thorax (2009) 2.00
Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. Am J Respir Crit Care Med (1996) 1.96
Effect of weight loss on upper airway collapsibility in obstructive sleep apnea. Am Rev Respir Dis (1991) 1.89
Human adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain. J Virol (1995) 1.88
Granzyme B directly and efficiently cleaves several downstream caspase substrates: implications for CTL-induced apoptosis. Immunity (1998) 1.88
Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension. Eur Respir J (2009) 1.85
Vision substitution by tactile image projection. Nature (1969) 1.83
Measuring adherence to asthma medication regimens. Am J Respir Crit Care Med (1994) 1.83
Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial. Arthritis Rheum (2000) 1.82
Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci U S A (1996) 1.82
Non-Invasive detection of respiratory effort-related arousals (REras) by a nasal cannula/pressure transducer system. Sleep (2000) 1.82
Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis. Ann Intern Med (2000) 1.79
Intracranial self-administration of morphine into the ventral tegmental area in rats. Life Sci (1981) 1.77
Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD? Eur Respir J (2008) 1.76
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial. Arthritis Rheum (1999) 1.75
Infectious purpura fulminans: diagnosis and treatment. Br J Haematol (1999) 1.74
Sindbis virus induces apoptosis through a caspase-dependent, CrmA-sensitive pathway. J Virol (1998) 1.71
Improving inhaler adherence in a clinical trial through the use of the nebulizer chronolog. Chest (1993) 1.70
Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study. Ann Rheum Dis (2006) 1.70
Ureteral calculi: diagnostic efficacy of helical CT and implications for treatment of patients. AJR Am J Roentgenol (1999) 1.66
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Arthritis Rheum (2008) 1.66
The neurobiology of craving: implications for the understanding and treatment of addiction. J Abnorm Psychol (1988) 1.65
The E2A gene product contains two separable and functionally distinct transcription activation domains. Proc Natl Acad Sci U S A (1993) 1.63
Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2000) 1.62
Superior vena cava syndrome. The myth--the facts. Am Rev Respir Dis (1990) 1.60
Neuroleptic-induced "anhedonia" in rats: pimozide blocks reward quality of food. Science (1978) 1.59
Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis. Arthritis Rheum (1992) 1.59
Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels. Br J Cancer (2007) 1.57
Vibrios from fish pen slime which mimic Escherichia coli on violet red bile agar. Appl Microbiol (1970) 1.57
Toxicity associated with long-term intravenous heroin and cocaine self-administration in the rat. JAMA (1985) 1.57
Recurrent transverse myelitis associates with anti-Ro (SSA) autoantibodies. Neurology (2004) 1.55
Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex. J Neurosci (1996) 1.53
Hsp60 accelerates the maturation of pro-caspase-3 by upstream activator proteases during apoptosis. EMBO J (1999) 1.52
Myasthenia gravis and upper airway obstruction. Chest (1996) 1.51
Renal function predicts colchicine toxicity: guidelines for the prophylactic use of colchicine in gout. J Rheumatol (1991) 1.51
A case-control study of the pathology of oesophageal disease in systemic sclerosis (scleroderma). Gut (2006) 1.50
Long-term metered-dose inhaler adherence in a clinical trial. The Lung Health Study Research Group. Am J Respir Crit Care Med (1995) 1.50
Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study. Ann Intern Med (1994) 1.50
Increased lever pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward. Science (1975) 1.49
A cDNA from a mouse pancreatic beta cell encoding a putative transcription factor of the insulin gene. Nucleic Acids Res (1990) 1.49
Pulmonary function and respiratory chemosensitivity in moderately obese patients with sleep apnea. Chest (1993) 1.49
Foot and ankle problems in rheumatoid arthritis. Foot Ankle Int (1994) 1.49
Integrating BRAF/MEK inhibitors into combination therapy for melanoma. Br J Cancer (2009) 1.48
Long-term clinical outcome in the Bypass Angioplasty Revascularization Investigation Registry: comparison with the randomized trial. BARI Investigators. Circulation (2000) 1.45
Impaired liver regeneration in inducible nitric oxide synthasedeficient mice. Proc Natl Acad Sci U S A (1998) 1.44
Annexin V binds to viable B cells and colocalizes with a marker of lipid rafts upon B cell receptor activation. J Immunol (2000) 1.44
Quantitative CT analysis of brain morphometry in adult Down's syndrome at different ages. Neurology (1987) 1.43
The prothrombin gene variant G20210A but not factor V leiden may be associated with veno-occlusive disease following BMT. Bone Marrow Transplant (1999) 1.43
Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats. Psychopharmacology (Berl) (1976) 1.43
Multimodality therapy in advanced paranasal sinus carcinoma: superior long-term results. Cancer J Sci Am (1999) 1.42
The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial. Arthritis Rheum (2001) 1.42
Gender difference in airway hyperresponsiveness in smokers with mild COPD. The Lung Health Study. Am J Respir Crit Care Med (1994) 1.42
A man with diabetes and a swollen leg. Lancet (1999) 1.41